These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24962632)

  • 21. Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases.
    Guerrieri C; Högberg T; Wingren S; Fristedt S; Simonsen E; Boeryd B
    Cancer; 1994 Oct; 74(8):2329-40. PubMed ID: 7922984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-grade Serous Carcinoma of the Ovary: Clinicopathologic Analysis of 52 Invasive Cases and Identification of a Possible Noninvasive Intermediate Lesion.
    Ahn G; Folkins AK; McKenney JK; Longacre TA
    Am J Surg Pathol; 2016 Sep; 40(9):1165-76. PubMed ID: 27487741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
    McCluggage WG; Young RH
    Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary.
    El-Balat A; Schmeil I; Karn T; Becker S; Sänger N; Holtrich U; Arsenic R
    Pathol Oncol Res; 2018 Apr; 24(2):277-282. PubMed ID: 28470574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of REG4 in ovarian mucinous tumors.
    Huang Q; Chen X; Lu W; Lai M; Lu B
    Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):295-301. PubMed ID: 23958547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
    Taylor J; McCluggage WG
    Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian mucinous and mixed epithelial carcinomas of mullerian (endocervical-like) type: a clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis.
    Lee KR; Nucci MR
    Int J Gynecol Pathol; 2003 Jan; 22(1):42-51. PubMed ID: 12496697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mucinous tumors of the ovary. Anatomo-clinical aspects, histological classification, prognostic factors and histogenesis].
    Bouzourene H; Genton CY
    Arch Anat Cytol Pathol; 1997; 45(4):192-8. PubMed ID: 9406476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
    McCluggage WG; Young RH
    Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive immunohistochemical analysis of the gastrointestinal and Müllerian phenotypes of 139 ovarian mucinous cystadenomas.
    Halimi SA; Maeda D; Ushiku-Shinozaki A; Goto A; Oda K; Osuga Y; Fujii T; Ushiku T; Fukayama M
    Hum Pathol; 2021 Mar; 109():21-30. PubMed ID: 33275953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian seromucinous tumors: clinicopathological features of 10 cases with a detailed review of the literature.
    Idrees R; Din NU; Siddique S; Fatima S; Abdul-Ghafar J; Ahmad Z
    J Ovarian Res; 2021 Mar; 14(1):47. PubMed ID: 33736662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pitfalls and common problems in the differential diagnosis of epithelial ovarian tumors].
    Lax SF
    Pathologe; 2019 Feb; 40(1):46-60. PubMed ID: 30719693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of pancreatic adenocarcinoma up-regulated factor expression in ovarian mucinous adenocarcinoma with poor prognosis.
    Kim SK; Song SY; Kim S; Cho NH; Yim GW; Kim SW; Kim YT; Nam EJ
    Int J Clin Exp Pathol; 2014; 7(8):5103-10. PubMed ID: 25197383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of c-myc and mutation of the KRAS gene in patients with ovarian mucinous tumors.
    Li XS; Sun J; He XL
    Genet Mol Res; 2015 Sep; 14(3):10752-9. PubMed ID: 26400304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma.
    Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H
    Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours.
    Fraggetta F; Pelosi G; Cafici A; Scollo P; Nuciforo P; Viale G
    Virchows Arch; 2003 Dec; 443(6):782-6. PubMed ID: 14576939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases.
    Tabrizi AD; Kalloger SE; Köbel M; Cipollone J; Roskelley CD; Mehl E; Gilks CB
    Int J Gynecol Pathol; 2010 Mar; 29(2):99-107. PubMed ID: 20173494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary.
    Chelariu-Raicu A; Holley E; Mayr D; Klauschen F; Wehweck F; Rottmann M; Kessler M; Kaltofen T; Czogalla B; Trillsch F; Mahner S; Schmoeckel E
    Int J Gynecol Cancer; 2022 May; 32(5):662-668. PubMed ID: 35185017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow-up.
    Hoerl HD; Hart WR
    Am J Surg Pathol; 1998 Dec; 22(12):1449-62. PubMed ID: 9850171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.